Jeffrey Hung
Stock Analyst at Morgan Stanley
(4.18)
Main Sectors:
42 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CRNX Crinetics Pharmaceut... | Maintains: Overweight | 65 77 | 40.86 | 88.45% | 3 | Sep 29, 2025 | |
RYTM Rhythm Pharmaceutica... | Maintains: Overweight | 109 122 | 99.02 | 23.21% | 13 | Sep 25, 2025 | |
JAZZ Jazz Pharmaceuticals | Maintains: Overweight | 163 167 | 139.48 | 19.73% | 10 | Sep 24, 2025 | |
CGON CG Oncology | Maintains: Overweight | 56 79 | 39.82 | 98.39% | 5 | Sep 17, 2025 | |
ENGN enGene Holdings | Maintains: Overweight | 19 18 | 7.75 | 132.26% | 4 | Sep 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 158 163 | 137.03 | 18.95% | 27 | Sep 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 76 71 | 65.37 | 8.61% | 13 | Aug 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 35 28 | 5.9 | 374.58% | 7 | Aug 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 21 | 11.35 | 85.02% | 4 | Aug 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 4 2 | 2.42 | -17.36% | 4 | Aug 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 13 | 8.37 | 55.32% | 6 | Aug 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 102 108 | 8.2 | 1217.07% | 5 | Jul 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 65 55 | 31.21 | 76.23% | 9 | Jul 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 24 | 21.8 | 10.09% | 25 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 85 | 67.78 | 25.41% | 6 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 27 | 23.23 | 16.23% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Underweight | 5 | 5.61 | -10.87% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 70 67 | 56.97 | 17.61% | 13 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 92 95 | n/a | n/a | 5 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 8.7 | 302.3% | 1 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 295 330 | n/a | n/a | 3 | Dec 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 4 | 1.47 | 172.11% | 10 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 13 4 | n/a | n/a | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 4 | 1.16 | 244.83% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 60 140 | n/a | n/a | 1 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 14 | 6.05 | 131.4% | 3 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 5 5 | 4.08 | 22.55% | 1 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 3 | 3.3 | -9.09% | 8 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 14 | 1.8 | 677.78% | 7 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 21 | n/a | n/a | 4 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 4 2 | n/a | n/a | 3 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 50 10 | 2.13 | 369.48% | 3 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 30 | n/a | n/a | 6 | Jan 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 22 | 40.09 | -45.12% | 10 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | n/a | n/a | 5 | Sep 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 250 94 | n/a | n/a | 8 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 146 149 | 15.81 | 839.28% | 2 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 180 | n/a | n/a | 12 | Oct 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 100 60 | 1.5 | 3900% | 5 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 4.86 | 23.46% | 9 | Apr 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 121 225 | n/a | n/a | 9 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 696 648 | 5.83 | 11014.92% | 6 | May 8, 2020 |